XML 23 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Interest Rate Swap
9 Months Ended
Sep. 30, 2016
Interest Rate Swap [Abstract]  
Interest Rate Swap

5. Interest Rate Swap

Risk Management Objective of Using Derivative Financial Instruments

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources and duration of its debt funding and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings.

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using interest rate derivative financial instruments are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swap and cap agreements as part of its interest rate risk management strategy. During the three months ended September 30, 2016, such derivative financial instruments were used to hedge the variable cash flows associated with existing variable-rate debt pursuant to the Term Loan Facility.

In January 2012, the Company executed three interest rate swap agreements with an aggregate notional amount of $640,000 to reduce the variability of interest payments associated with the Term Loan Facility. The interest rate swap agreements expire in February 2017. In March 2016, the Company executed two annuitized interest rate cap agreements with a combined notional amount of $650,000 to limit the exposure of the variable component of interest rates under the Term Loan Facility or future variable rate indebtedness to a maximum of 1.25%, beginning in March 2017 and expiring in March 2020. As of September 30, 2016, the Company’s outstanding interest rate swap agreements and interest rate cap agreements were designated as cash flow hedges of interest rate risk and determined to be highly effective.

The effective portion of changes in the fair value of derivative financial instruments designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivative financial instruments is recognized directly in earnings. Amounts reported in accumulated other comprehensive income related to derivative financial instruments will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. During the next twelve months, the Company estimates that an additional $1,427 will be reclassified as an increase to interest expense.

The following table summarizes the fair value of the Company’s derivative financial instruments at September 30, 2016 and December 31, 2015:

 





 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 



 

Fair Values of Derivative Financial Instruments



 

Asset (Liability)

Derivative financial instruments designated as hedging instruments:

 

Balance Sheet Location

 

September 30, 2016

December 31, 2015

Interest rate swap and cap agreements

 

Accrued expenses

 

$

(2,527)

 

$

(1,870)

Interest rate swap and cap agreements

 

Other long-term liabilities

 

 

(3,897)

 

 

(556)



 

 

 

$

(6,424)

 

$

(2,426)



Tabular Disclosure of the Effect of Derivative Financial Instruments on the Statement of Operations

The effect of the derivative financial instruments on the accompanying unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2016 and 2015, respectively, is summarized in the following table:

 





 

 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended
September 30,

 

Three Months Ended
September 30,

 

Nine Months Ended
September 30,

 

Nine Months Ended
September 30,

 



 

2016

 

2015

 

2016

 

2015

 

Derivative financial instruments in cash flow hedging relationships:

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain/ (loss) related to effective portion of derivative financial instruments recognized in other comprehensive loss

 

$

(71)

 

$

(645)

 

$

(5,867)

 

$

(2,695)

 

Gain/ (loss) related to effective portion of derivative financial instruments reclassified from accumulated other comprehensive loss to interest expense

 

$

(652)

 

$

(652)

 

$

(1,942)

 

$

(1,935)

 

Gain/ (loss) related to ineffective portion of derivative financial instruments recognized in interest expense

 

$

30 

 

$

 —

 

$

(71)

 

$

 —

 



Credit Risk-related Contingent Features

The Company has agreements with each of its derivative financial instrument counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company also could be declared in default on its derivative financial instrument obligations.



As of September 30, 2016, the termination value of the Company’s derivative financial instruments in a net liability position, which includes accrued interest but excludes any adjustment for nonperformance risk, related to these agreements was $7,341. If the Company had breached any of these provisions at September 30, 2016, the Company could have been required to settle its obligations under the agreements at this termination value. The Company does not offset any derivative financial instruments, and the derivative financial instruments are not subject to collateral posting requirements.